Happy New Year! I hope that you all have recovered from the joy, and often stress, of the holiday season. As we step into 2024, I am eager to share some CIS updates with you.
FDA Proposed Rule on LDTs
As many of you know, the FDA recently proposed new rules regarding laboratory developed tests. CIS considered the impact that these proposed rules regarding laboratory developed tests may have on diagnostic testing provided to patients with inborn errors of immunity. In an effort to address concerns, CIS wrote a letter to the FDA during the comment period. You can read that letter here.
CIS Summer School
Our flagship course, the CIS Summer School, returned in sunny Pompano Beach, FL at the end of October much to the enjoyment of all involved. We had a great course with incredible fellows. Thank you to our fellows and faculty for making this another incredible year.
Annual Meeting 2024
We are deep into planning the program for 2024 and can’t wait to see you all in Minneapolis, MN, May 1-4, 2024 at the Renaissance Minneapolis Hotel, The Depot. Registration is now open and we encourage you to register now to maximize your advantage of an early bird rate. NEW FOR 2024: The pre-conference education day is now included in the price of registration! There is no separate fee to attend the session and attendees may choose to attend any and/or all of the sessions on Wednesday morning to early afternoon. Our 2024 Annual Meeting will be fully in-person with an option to purchase on-demand content after the conference if you cannot attend in person. You can learn more about the Annual Meeting here.
As always, please reach out with any questions or comments at any time.
In collegiality,
Elie Haddad, MD, PhD
CIS President